Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
17.25Prev. Close
16.44Volume
158Total traded value
0.00 CrUpper Circuit
17.26Lower Circuit
15.62Fundamentals
| Market Cap | ₹16Cr |
| ROE | 8.32% |
| P/E Ratio(TTM) | -13.93 |
| EPS(TTM) | -1.18 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.14 |
| Book Value | -14.79 |
| Debt to Equity | -1.45 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Norris Medicines
Norris Medicines is a healthcare company specializing in contract manufacturing for large multinational and Indian pharmaceutical firms. The company focuses on increasing volume and improving efficiency by implementing robust cost reduction methods and strengthening its quality standards. Notably, both of the company's manufacturing plants are WHO GMP approved, ensuring high-quality production standards.;
| Parent Organisation | Norris Medicines Limited |
| BSE Symbol | 524414 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.18 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
| Wockhardt | NA (0.00%) | -195.86 |